BRÈVE publiée le 15/10/2024 à 15:05, il y a 1 mois 5 jours KindlyMD annonce un programme de rachat d'actions de 500 000 $ Rachat D'actions Valeur Actionnariale KindlyMD Conditions Du Marché Entreprise De Soins De Santé
BRÈVE publiée le 15/10/2024 à 15:05, il y a 1 mois 5 jours KindlyMD Announces $500,000 Stock Repurchase Program Shareholder Value Market Conditions Stock Repurchase Healthcare Company KindlyMD
COMMUNIQUÉ DE PRESSE publié le 15/10/2024 à 15:00, il y a 1 mois 5 jours KindlyMD(TM) Announces $500,000 Share Repurchase Program KindlyMD, Inc. authorizes a $500,000 stock repurchase program, aiming to enhance shareholder value. The program may be made through various methods, considering market conditions Shareholder Value Stock Repurchase KindlyMD Patient-first Healthcare Integrated Therapies
BRÈVE publiée le 08/10/2024 à 15:05, il y a 1 mois 12 jours KindlyMD Secures Contract with UnitedHealthcare Healthcare Expansion Utah KindlyMD UnitedHealthcare Health Insurance
BRÈVE publiée le 08/10/2024 à 15:05, il y a 1 mois 12 jours KindlyMD signe un contrat avec UnitedHealthcare Utah Expansion Des Soins De Santé KindlyMD UnitedHealthcare Assurance Maladie
COMMUNIQUÉ DE PRESSE publié le 08/10/2024 à 15:00, il y a 1 mois 12 jours KindlyMD(TM) Announces Contract with United Healthcare Insurance, the Largest Health Insurer in the United States KindlyMD, Inc. announces its new contract with UnitedHealthcare Insurance, expanding coverage and access for patients in Utah, leading to potential revenue growth Utah Contract KindlyMD UnitedHealthcare Expanded Coverage
BRÈVE publiée le 01/10/2024 à 15:05, il y a 1 mois 19 jours KindlyMD(TM) to Participate in Upcoming October Conferences Medical Cannabis KindlyMD Tim Pickett Benzinga Conference LD Micro
BRÈVE publiée le 01/10/2024 à 15:05, il y a 1 mois 19 jours KindlyMD(TM) participera aux prochaines conférences d'octobre Cannabis Médical KindlyMD Tim Pickett LD Micro Conférence De Benzinga
COMMUNIQUÉ DE PRESSE publié le 01/10/2024 à 15:00, il y a 1 mois 19 jours KindlyMD(TM) to Participate in Upcoming October Conferences KindlyMD, Inc. CEO to participate in investor conferences discussing medical cannabis experience best practices. Company integrates healthcare strategies with alternative therapies Investor Conferences Medical Cannabis KindlyMD Inc. Healthcare Data Alternative Therapies
BRÈVE publiée le 12/09/2024 à 15:05, il y a 2 mois 8 jours KindlyMD Recognized with Healthcare AI Impact Award 2024 AI Healthcare Medical Cannabis Awards Patient Data
Publié le 21/11/2024 à 06:58, il y a 7 heures 17 minutes Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Publié le 21/11/2024 à 06:58, il y a 7 heures 17 minutes Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Publié le 21/11/2024 à 06:58, il y a 7 heures 17 minutes Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Publié le 20/11/2024 à 20:07, il y a 18 heures 8 minutes Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Publié le 20/11/2024 à 19:20, il y a 18 heures 55 minutes Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Publié le 21/11/2024 à 14:00, il y a 15 minutes Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Publié le 21/11/2024 à 14:00, il y a 15 minutes Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Publié le 21/11/2024 à 14:00, il y a 15 minutes Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Publié le 21/11/2024 à 13:30, il y a 45 minutes AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Publié le 21/11/2024 à 13:41, il y a 34 minutes Original-Research: Pentixapharm Holding AG (von BankM AG): Kaufen
Publié le 21/11/2024 à 12:35, il y a 1 heure 40 minutes audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Publié le 21/11/2024 à 12:15, il y a 2 heures Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
